Saki Ichikawa

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 2

Top Topics

High Fat Diet Induced

Diabetic Nephropathy

Ischemia Reperfusion Injury

Nitric Oxide Synthase

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Zi Li, Maki Murakoshi, Saki Ichikawa, Takeo Koshida, Eri Adachi, Chigure Suzuki, Seiji Ueda, Tomohito Gohda, Yusuke Suzuki
The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice. FEBS open bio 10 (12) (2020)
Saki Ichikawa, Tomohito Gohda, Maki Murakoshi, Zi Li, Eri Adachi, Takeo Koshida, Yusuke Suzuki
Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice. FEBS open bio 10 (6) (2020)